Idexx Laboratories holds $3.4B in total assets. Shareholders' equity is $1.6B against $575.5M in total debt. Cash and equivalents total $200.5M. The current ratio is 1.12 and debt-to-equity is 0.370. Based on the Q1 2026 filing.